Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leah M Prentice

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Diagnostic Pathology|August 24, 2017
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutationEmiko Udo, Bungo Furusato, Kazuko Sakai, et al.
Plos One|April 27, 2018
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practiceLeah M Prentice, Ruth R Miller, Jeff Knaggs, et al.
Plos One|November 10, 2011
Mll5 is required for normal spermatogenesisDamian B Yap, David C Walker, Leah M Prentice, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
BMC Medicine|November 17, 2007
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinomaLeah M Prentice, Christian Klausen, Steve Kalloger, et al.
Plos One|August 24, 2012
Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumorsAnamaria Crisan, Rodrigo Goya, Gavin Ha, et al.
Plos One|October 12, 2013
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Plos One|September 12, 2013
Type-specific cell line models for type-specific ovarian cancer researchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
BMC Genomics|April 30, 2011
The testosterone-dependent and independent transcriptional networks in the hypothalamus of Gpr54 and Kiss1 knockout male mice are not fully equivalentLeah M Prentice, Xavier d'Anglemont de Tassigny, Steven McKinney, et al.
Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Diagnostic Pathology|August 24, 2017
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutationEmiko Udo, Bungo Furusato, Kazuko Sakai, et al.
Plos One|April 27, 2018
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practiceLeah M Prentice, Ruth R Miller, Jeff Knaggs, et al.
Plos One|November 10, 2011
Mll5 is required for normal spermatogenesisDamian B Yap, David C Walker, Leah M Prentice, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
BMC Medicine|November 17, 2007
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinomaLeah M Prentice, Christian Klausen, Steve Kalloger, et al.
Plos One|August 24, 2012
Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumorsAnamaria Crisan, Rodrigo Goya, Gavin Ha, et al.
Plos One|October 12, 2013
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Plos One|September 12, 2013
Type-specific cell line models for type-specific ovarian cancer researchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
BMC Genomics|April 30, 2011
The testosterone-dependent and independent transcriptional networks in the hypothalamus of Gpr54 and Kiss1 knockout male mice are not fully equivalentLeah M Prentice, Xavier d'Anglemont de Tassigny, Steven McKinney, et al.
Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.
Pageof 3